Platform
Pipeline
Partners
News & Media
About
Careers
Contact
Investors
Presentation
October 30, 2025
Promise & Reality: Decoding AI’s Impact On Drug Development
Related articles
Publication
October 14, 2026
Iambic Announces Pricing of Initial Public Offering
Read more
Publication
October 5, 2026
Iambic Submits IND for a Potentially Brain-Penetrant KIF18A Inhibitor IAM217, Its Second Wholly Owned AI-Discovered Candidate
Read more
Publication
September 21, 2026
Iambic Launches Enchant v3 – Molecular Superintelligence Designed to Advance End-to-End Drug Discovery & Development
Read more
View more
Let's work together
Leverage the Iambic discovery process for your program. Reach out to us at partnerships@iambic.ai.
Contact us